摘要:
A refrigerator, includes a cabinet having a refrigerating compartment therein; a door pivotably coupled with the cabinet to open or close the refrigerating compartment; and an auxiliary door-opening device. The auxiliary door-opening device includes: a swing arm, a servo driver which is disposed on the cabinet, has an output shaft coupled with the swing arm, and is configured to drive the swing arm to swing between a first predetermined position in which the swing arm pushes the door to separate from the cabinet and a second predetermined position in which the door is closed onto the cabinet; and a controller configured to actuate the servo driver when receiving a door-opening instruction, so that the servo driver drives the swing arm to move to the first predetermined position and then to return to the second predetermined position.
摘要:
A refrigerator, includes a cabinet having a refrigerating compartment therein; a door pivotably coupled with the cabinet to open or close the refrigerating compartment; and an auxiliary door-opening device. The auxiliary door-opening device includes: a swing arm, a servo driver which is disposed on the cabinet, has an output shaft coupled with the swing arm, and is configured to drive the swing arm to swing between a first predetermined position in which the swing arm pushes the door to separate from the cabinet and a second predetermined position in which the door is closed onto the cabinet; and a controller configured to actuate the servo driver when receiving a door-opening instruction, so that the servo driver drives the swing arm to move to the first predetermined position and then to return to the second predetermined position.
摘要:
The present invention discloses novel compounds of Formula I: (I) possessing 11β-HSD type 1 antagonist activity, as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula I, as well as methods of using the compounds and compositions to treat diabetes, hyperglycemia, obesity, hypertension, hyperlipidemia, metabolic syndrome, cognitive disorders, and other conditions associated with 11β-HSD type 1 activity.
摘要:
The present invention discloses novel compounds of Formula I: having 11β-HSD type 1 antagonist activity, as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula I, as well as methods of using the compounds and compositions to treat diabetes, hyperglycemia, obesity, hypertension, hyperlipidemia, metabolic syndrome, and other conditions associated with 11β-HSD type 1 activity.
摘要:
The present invention discloses novel compounds of Formula I: possessing 11 β-HSD type 1 antagonist activity, as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula I, as well as methods of using the compounds and compositions to treat diabetes, hyperglycemia, obesity, hypertension, hyperlipidemia, metabolic syndrome, cognitive disorders, and other conditions associated with 11 β-HSD type 1 activity.
摘要:
The present invention provides serotonergic aminoalkylbenzofurans of Formula (I): where R, R1, R2, R3, R4, R4′, R5, R5′, and R12 are as described in the specification.
摘要:
The present invention discloses novel compounds of Formula I: (I) having 11-HSD type 1 antagonist activity, as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula I, as well as methods of using the compounds and compositions to treat diabetes, hyperglycemia, obesity, hypertension, hyperlipidemia, metabolic syndrome, and other conditions associated with 11-HSD type 1 activity.
摘要:
The present invention discloses novel compounds of Formula I: (I) having 11β-HSD type 1 antagonist activity, as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula I, as well as methods of using the compounds and compositions to treat diabetes, hyperglycemia, obesity, hypertension, hyperlipidemia, metabolic syndrome, and other conditions associated with 11β-HSD type 1 activity.
摘要:
The present invention discloses novel compounds of Formula I: having 11β-HSD type 1 antagonist activity, as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula I, as well as methods of using the compounds and compositions to treat diabetes, hyperglycemia, obesity, hypertension, hyperlipidemia, metabolic syndrome, and other conditions associated with 11β-HSD type 1 activity.